WANG Zhi-jie, FU Rui. Neoadjuvant Crizotinib in Resectable Locally Advanced Non-Small Cell Lung Cancer with ALK-Rearrangement: A Brief Report[J]. Journal of Evidence-Based Medicine, 2019, 19(1): 39-43. DOI: 10.12019/j.issn.1671-5144.2019.01.011
|
Citation:
|
WANG Zhi-jie, FU Rui. Neoadjuvant Crizotinib in Resectable Locally Advanced Non-Small Cell Lung Cancer with ALK-Rearrangement: A Brief Report[J]. Journal of Evidence-Based Medicine, 2019, 19(1): 39-43. DOI: 10.12019/j.issn.1671-5144.2019.01.011
|
WANG Zhi-jie, FU Rui. Neoadjuvant Crizotinib in Resectable Locally Advanced Non-Small Cell Lung Cancer with ALK-Rearrangement: A Brief Report[J]. Journal of Evidence-Based Medicine, 2019, 19(1): 39-43. DOI: 10.12019/j.issn.1671-5144.2019.01.011
|
Citation:
|
WANG Zhi-jie, FU Rui. Neoadjuvant Crizotinib in Resectable Locally Advanced Non-Small Cell Lung Cancer with ALK-Rearrangement: A Brief Report[J]. Journal of Evidence-Based Medicine, 2019, 19(1): 39-43. DOI: 10.12019/j.issn.1671-5144.2019.01.011
|
DownLoad: